[FG] Walker Ulrich

Sekulic, Marijana et al. (2024) ‘Neutrophil extracellular traps affect human inner ear vascular permeability’, International Journal of Molecular Sciences. 10.09.2024, 25(18), p. 13. Available at: https://doi.org/10.3390/ijms25189766.

Deibel, Elisabeth et al. (2024) ‘Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?’, Arthritis Care and Research, 76, pp. 88–97. Available at: https://doi.org/10.1002/acr.25226.

Giaglis, S. (2023) ‘Poised to cast wide NETs in long COVID’, Journal of Thrombosis and Haemostasis, 21, pp. 2362–2364. Available at: https://doi.org/10.1016/j.jtha.2023.06.005.

Giaglis, Stavros et al. (2023) ‘Mitochondrial DNA: A novel indicator of active inflammation in ANCA-Associated vasculitides’, Rheumatology (United Kingdom), 62, pp. 2930–2937. Available at: https://doi.org/10.1093/rheumatology/kead015.

Guler, Sabina et al. (2023) ‘Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: A EUSTAR database analysis’, Thorax, 78, pp. 1188–1196. Available at: https://doi.org/10.1136/thorax-2023-220541.

Lepri, Gemma et al. (2023) ‘Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes’, Journal of Scleroderma and Related Disorders, 8, pp. 210–220. Available at: https://doi.org/10.1177/23971983231155948.

Bruni C et al. (2022) ‘Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.’, Rheumatology (Oxford, England), 61(10), pp. 4035–4046. Available at: https://doi.org/10.1093/rheumatology/keac126.

Iudici M. et al. (2022) ‘Representativeness of systemic sclerosis patients in interventional randomized trials: An analysis of the EUSTAR database’, Rheumatology (United Kingdom), 61(2), pp. 743–755. Available at: https://doi.org/10.1093/rheumatology/keab437.

Arnold S. et al. (2022) ‘Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors’, Rheumatology (United Kingdom), 61(1), pp. 131–138. Available at: https://doi.org/10.1093/rheumatology/keab343.

Mischlinger, J. et al. (2022) ‘Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls’, Vaccine, 40(33), pp. 4897–4904. Available at: https://doi.org/10.1016/j.vaccine.2022.06.013.

Ritter F et al. (2022) ‘Gout Arthritis During Admission for Decompensated Heart Failure-A Descriptive Analysis of Risk Factors, Treatment and Prognosis.’, Frontiers in medicine, 9, p. 789414. Available at: https://doi.org/10.3389/fmed.2022.789414.

Roessinger, Olivier et al. (2022) ‘Polg mtDNA mutator mice reveal limited involvement of vertebral bone loss in premature aging-related thoracolumbar hyperkyphosis’, Bone Reports, 17, p. 101618. Available at: https://doi.org/10.1016/j.bonr.2022.101618.

Giaglis S et al. (2021) ‘Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus.’, RMD open, 7(3). Available at: https://doi.org/10.1136/rmdopen-2021-002010.

Lechtenboehmer C.A. et al. (2021) ‘Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis’, Arthritis Research and Therapy, 23(1). Available at: https://doi.org/10.1186/s13075-021-02654-0.

Giaglis, S. et al. (2021) Circulatory neutrophils exhibit enhanced neutrophil extracellular trap formation in early puerperium: NETs at the nexus of thrombosis and immunity? Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.10.18.459827.

Manoil D. et al. (2021) ‘Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis’, Rheumatology (United Kingdom), 60(10), pp. 4755–4764. Available at: https://doi.org/10.1093/rheumatology/keab097.

Saketkoo L.A. et al. (2021) ‘A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc’, Best Practice and Research: Clinical Rheumatology, 35(3). Available at: https://doi.org/10.1016/j.berh.2021.101707.

Hernández J et al. (2021) ‘The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort.’, Swiss medical weekly, 151, p. w20528. Available at: https://doi.org/10.4414/smw.2021.20528.

Kalweit M. et al. (2021) ‘Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network’, PLoS ONE, 16(6 June). Available at: https://doi.org/10.1371/journal.pone.0252289.

Walker U.A. et al. (2021) ‘Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: Results from the β-Confident Registry’, RMD Open, 7(2). Available at: https://doi.org/10.1136/rmdopen-2021-001663.

Shaw Y. et al. (2021) ‘Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction’, RMD Open, 7(1). Available at: https://doi.org/10.1136/rmdopen-2021-001566.

Vonk M.C. et al. (2021) ‘Natural variability in the disease course of SSC-ILD: Implications for treatment’, European Respiratory Review, 30(159). Available at: https://doi.org/10.1183/16000617.0340-2020.

Spierings J. et al. (2021) ‘A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol’, BMJ Open, 11(3). Available at: https://doi.org/10.1136/bmjopen-2020-044483.

Giaglis, Stavros et al. (2021) ‘Circulatory neutrophils exhibit enhanced neutrophil extracellular trap formation in early puerperium: NETs at the nexus of thrombosis and immunity’, International Journal of Molecular Sciences, 22. Available at: https://doi.org/10.3390/ijms222413646.

Kocher, Agnes et al. (2021) ‘A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model’, Orphanet journal of rare diseases, 16(1), p. 356. Available at: https://doi.org/10.1186/s13023-021-01944-9.

Kocher, Agnes et al. (2021) ‘Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods study’, RMD Open, 7(3), p. e001783. Available at: https://doi.org/10.1136/rmdopen-2021-001783.

Geurts J et al. (2020) ‘Prematurely aging mitochondrial DNA mutator mice display subchondral osteopenia and chondrocyte hypertrophy without further osteoarthritis features’, Scientific Reports, 10(1). Available at: https://doi.org/10.1038/s41598-020-58385-w.

Fallet B. and Walker U.A. (2020) ‘Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies’, Expert Review of Clinical Pharmacology, 13(11), pp. 1203–1218. Available at: https://doi.org/10.1080/17512433.2020.1832466.

Erzer J.N. et al. (2020) ‘Systemic sclerosis in sub-saharan Africa: A systematic review’, Pan African Medical Journal, 37, pp. 1–18. Available at: https://doi.org/10.11604/pamj.2020.37.176.22557.

Fallet B, Kyburz D and Walker U.A. (2020) ‘Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment’, Arthritis and Rheumatology, 72(9), pp. 1581–1582. Available at: https://doi.org/10.1002/art.41380.

Jaeger V.K. et al. (2020) ‘Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study’, Rheumatology (United Kingdom), 59(7), pp. 1684–1694. Available at: https://doi.org/10.1093/rheumatology/kez486.

Stoikou M et al. (2020) ‘G-CSF Infusion for Stem Cell Mobilization Transiently Increases Serum Cell-Free DNA and Protease Concentrations’, Frontiers in Medicine, 7, p. 155. Available at: https://doi.org/10.3389/fmed.2020.00155.

Hoffmann-Vold A.-M. et al. (2020) ‘The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements’, The Lancet Rheumatology, 2(2), pp. e71–e83. Available at: https://doi.org/10.1016/s2665-9913(19)30144-4.

Blagojevic J. et al. (2020) ‘Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study’, Clinical Rheumatology, 39(1), pp. 27–36. Available at: https://doi.org/10.1007/s10067-019-04564-8.

Burkhard, J. et al. (2020) ‘Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals’, Vaccine, 38(19), pp. 3610–3617. Available at: https://doi.org/10.1016/j.vaccine.2019.12.042.

Kingston C. et al. (2020) ‘Lumbar Radiculitis as a Complication of Vaccination against Tick-Borne Encephalitis: A Differential Diagnosis of Low Back Pain and Nerve Root Compression’, Case Reports in Medicine, 2020. Available at: https://doi.org/10.1155/2020/6130364.

Schmid, N. et al. (2020) ‘Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: a multi-centre, observational study’, Travel Med Infect Dis, 38, p. 101818. Available at: https://doi.org/10.1016/j.tmaid.2020.101818.

Fasano S. et al. (2019) ‘Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual’, Annals of the Rheumatic Diseases, 78(12), pp. 1681–1685. Available at: https://doi.org/10.1136/annrheumdis-2019-215787.

Jaeger VK et al. (2019) ‘Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis’, Scientific Reports, 9(1). Available at: https://doi.org/10.1038/s41598-019-41933-4.

Jaeger V.K. and Walker U.A. (2019) ‘Raynaud’s phenomenon: no net effects of vasodilators in a network analysis’, The Lancet Rheumatology, 1(4), pp. e200–e202. Available at: https://doi.org/10.1016/s2665-9913(19)30109-2.

Smith V. et al. (2019) ‘Fast track algorithm: How to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”’, Autoimmunity Reviews, 18(11). Available at: https://doi.org/10.1016/j.autrev.2019.102394.

Valentini G. et al. (2019) ‘Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study’, Annals of the Rheumatic Diseases, 78(11), pp. 1576–1582. Available at: https://doi.org/10.1136/annrheumdis-2019-215486.

Becker M. et al. (2019) ‘Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis’, Annals of the Rheumatic Diseases, 78(9), pp. 1242–1248. Available at: https://doi.org/10.1136/annrheumdis-2019-215145.

Bratu VA et al. (2019) ‘Do Patients With Skin Psoriasis Show Subclinical Axial Inflammation on Magnetic Resonance Imaging of the Sacroiliac Joints and Entire Spine?’, Arthritis Care and Research, 71(8), pp. 1109–1118. Available at: https://doi.org/10.1002/acr.23767.

Hargreaves P et al. (2019) ‘Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome’, Arthritis research & therapy, 21(1), p. 175. Available at: https://doi.org/10.1186/s13075-019-1955-2.

Wu W. et al. (2019) ‘Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort’, Annals of the Rheumatic Diseases, 78(5), pp. 648–656. Available at: https://doi.org/10.1136/annrheumdis-2018-213455.

Osthoff M et al. (2019) ‘Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: A cross-sectional study’, Arthritis Research and Therapy, 21(1). Available at: https://doi.org/10.1186/s13075-019-1859-1.

Blagojevic J. et al. (2019) ‘Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: A DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey’, Arthritis Research and Therapy, 21(1). Available at: https://doi.org/10.1186/s13075-019-1822-1.

Carreira PE et al. (2019) ‘Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database’, Scandinavian Journal of Rheumatology, 48(1), pp. 42–51. Available at: https://doi.org/10.1080/03009742.2018.1459830.

Bühler, Silja et al. (2019) ‘Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study’, Rheumatology, 58(9), pp. 1585–1596. Available at: https://doi.org/10.1093/rheumatology/kez045.

Lechtenboehmer CA et al. (2019) ‘Brief Report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis’, Arthritis and Rheumatology, 71(1), pp. 43–49. Available at: https://doi.org/10.1002/art.40684.

Jaeger VK et al. (2018) ‘Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.’, Arthritis & rheumatology (Hoboken, N.J.). 24.09.2018, 70(11), pp. 1829–1834. Available at: https://doi.org/10.1002/art.40557.

Walker UA et al. (2018) ‘Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study.’, Arthritis research & therapy. 25.10.2018, 20(1), p. 239. Available at: https://doi.org/10.1186/s13075-018-1733-6.

Carreira PE et al. (2018) ‘Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.’, Clinical and experimental rheumatology. 29.09.2018, 36 Suppl 113(4), pp. 68–75.

Walker UA, Luetke Volksbeck S and Kuemmerle-Deschner J (2018) ‘Flare of a Cryopyrin-associated Periodic Syndrome Following Vaccination with Neisseria Meningitidis Polysaccharides.’, 45(6). Available at: https://doi.org/10.3899/jrheum.171037.

Beyer C et al. (2018) ‘Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.’, Annals of the rheumatic diseases, 77(4), pp. 626–628. Available at: https://doi.org/10.1136/annrheumdis-2016-210834.

Ebrahimi F et al. (2018) ‘Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial.’, The European respiratory journal, 51(4). Available at: https://doi.org/10.1183/13993003.01389-2017.

Jaeger VK et al. (2018) ‘Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.’, Rheumatology (Oxford, England), 57(3), pp. 441–450. Available at: https://doi.org/10.1093/rheumatology/kex182.

Adler S et al. (2018) ‘Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.’, Arthritis research & therapy. 30.01.2018, 20(1), p. 17. Available at: https://doi.org/10.1186/s13075-018-1517-z.

Johnson SR et al. (2018) ‘There is a need for new systemic sclerosis subset criteria. A content analytic approach.’, Scandinavian journal of rheumatology. 09.10.2017, 47(1), pp. 62–70. Available at: https://doi.org/10.1080/03009742.2017.1299793.

Walker UA, Saketkoo LA and Distler O (2018) ‘Haematopoietic stem cell transplantation in systemic sclerosis.’, RMD open. 17.06.2018, 4(1), p. e000533. Available at: https://doi.org/10.1136/rmdopen-2017-000533.

Elhai M et al. (2017) ‘Mapping and predicting mortality from systemic sclerosis.’, Annals of the rheumatic diseases. 23.08.2017, 76(11), pp. 1897–1905. Available at: https://doi.org/10.1136/annrheumdis-2017-211448.

Walker UA (2017) ‘Trial of Tocilizumab in Giant-Cell Arteritis.’, 377(15). Available at: https://doi.org/10.1056/nejmc1711031.

Jaeger, Veronika K. et al. (2017) ‘Patient’s Self-Monitoring of Disease Activity of Rheumatic Diseases Via Webapp - Study Design, Patient’s Perspective and Recruitment in the First 16 Months of a Swiss Multicentre, Longitudinal Study’. WILEY, 69.

Jaeger, Veronika K. et al. (2017) ‘Mitochondrial DNA Mutations and Respiratory Chain Dysfunction in Lung Fibrosis of Systemic Sclerosis’. WILEY, 69.

Walker UA et al. (2017) ‘Disease activity dynamics in rheumatoid arthritis: patients” self-assessment of disease activity via WebApp.’, Rheumatology (Oxford, England), 56(10), pp. 1707–1712. Available at: https://doi.org/10.1093/rheumatology/kex229.

Allanore Y et al. (2017) ‘Points to consider when doing a trial primarily involving the heart.’, Rheumatology (Oxford, England), 56(suppl_5), pp. v12–v16. Available at: https://doi.org/10.1093/rheumatology/kex198.

Alpizar-Rodriguez D et al. (2017) ‘Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.’, Rheumatology (Oxford, England), 56(9), pp. 1579–1585. Available at: https://doi.org/10.1093/rheumatology/kex239.

Carreira PE et al. (2017) ‘Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis.’, Clinical and experimental rheumatology. 20.06.2017, 35 Suppl 106(4), pp. 114–121.

Jaeger VK et al. (2017) ‘Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.’, 56(9). Available at: https://doi.org/10.1093/rheumatology/kex185.

Walker UA et al. (2017) ‘Muscle involvement in systemic sclerosis: points to consider in clinical trials.’, Rheumatology (Oxford, England), 56(suppl_5), pp. v38–v44. Available at: https://doi.org/10.1093/rheumatology/kex196.

Keck, A. D., Jaeger, V. K. and Walker, U. A. (2017) ‘Myositis in Systemic Sclerosis, Lupus Erythematosus and Sjogren’s Syndrome’, AKTUELLE RHEUMATOLOGIE. WOS.SCI, 42, pp. 310–315. Available at: https://doi.org/10.1055/s-0042-112361.

Landmann EC and Walker UA (2017) ‘Pharmacological treatment options for cryopyrin-associated periodic syndromes.’, Expert review of clinical pharmacology, 10(8), pp. 855–864. Available at: https://doi.org/10.1080/17512433.2017.1338946.

Stoikou, Maria et al. (2017) ‘Gestational diabetes mellitus is associated with altered neutrophil activity’, Frontiers in Immunology, 8(JUN), p. 702. Available at: https://doi.org/10.3389/fimmu.2017.00702.

Blagojevic, J. et al. (2017) ‘CLASSIFICATION, CATEGORISATION AND ESSENTIAL ITEMS FOR DIGITAL ULCER (DU) EVALUATION IN SYSTEMIC SCLEROSIS (SSC): A DESSCIPHER/EUSTAR SURVEY’. BMJ PUBLISHING GROUP, 76. Available at: https://doi.org/10.1136/annrheumdis-2017-eular.6815.

Jaeger, V. K. et al. (2017) ‘FREQUENT, UNUSUALLY SEVERE, LONG LASTING, LOCAL AND SYSTEMIC PNEUMOCOCCAL VACCINE REACTIONS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS): RESULTS OF A PROSPECTIVE REGISTRY BASED STUDY’. BMJ PUBLISHING GROUP, 76. Available at: https://doi.org/10.1136/annrheumdis-2017-eular.1513.

Jaeger, V. K. et al. (2017) ‘SMOKING BEHAVIOUR AND THE PROGRESSION OF ORGAN MANIFESTATIONS IN SYSTEMIC SCLEROSIS: A LONGITUDINAL EUROPEAN SCLERODERMA TRIALS AND RESEARCH GROUP STUDY’. BMJ PUBLISHING GROUP, 76. Available at: https://doi.org/10.1136/annrheumdis-2017-eular.2729.

Walker, U. A. et al. (2017) ‘PROSPECTIVE EVALUATION OF THE CAPILLAROSCOPIC SKIN ULCER INDEX (CSURI) IN CLINICAL PRACTICE’. BMJ PUBLISHING GROUP, 76. Available at: https://doi.org/10.1136/annrheumdis-2017-eular.1827.

Alpizar-Rodriguez D et al. (2017) ‘The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.’, Clinical rheumatology. 21.01.2017, 36(3), pp. 677–682. Available at: https://doi.org/10.1007/s10067-017-3547-3.

Kapelouzou A et al. (2017) ‘Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment.’, Journal of vascular research, 54(3), pp. 156–169. Available at: https://doi.org/10.1159/000457797.

Kowal-Bielecka, Otylia et al. (2017) ‘Update of EULAR recommendations for the treatment of systemic sclerosis’, Annals of the Rheumatic Diseases, 76(8), pp. 1327–1339. Available at: https://doi.org/10.1136/annrheumdis-2016-209909.

Valentini G et al. (2017) ‘The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.’, 76(1). Available at: https://doi.org/10.1136/annrheumdis-2016-209768.

Loetscher J, Fistarol S and Walker UA (2016) Pyoderma Gangrenosum and Erythema Nodosum Revealing Takayasu’s Arteritis. 3, pp. 354–357. Available at: https://doi.org/10.1159/000452829.

Jaeger VK and Walker UA (2016) ‘Erectile Dysfunction in Systemic Sclerosis.’, Current rheumatology reports, 18(8), p. 49. Available at: https://doi.org/10.1007/s11926-016-0597-5.

Wirz EG et al. (2016) ‘Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.’, Annals of the rheumatic diseases. 31.07.2015, 75(7), pp. 1285–92. Available at: https://doi.org/10.1136/annrheumdis-2015-207271.

Mihai C et al. (2016) ‘Digital ulcers predict a worse disease course in patients with systemic sclerosis.’, Annals of the rheumatic diseases. 16.02.2015, 75(4), pp. 681–6. Available at: https://doi.org/10.1136/annrheumdis-2014-205897.

Walker UA (2016) ‘Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugs.’, Seminars in hematology. 07.04.2016, 53 Suppl 1, pp. S58–60. Available at: https://doi.org/10.1053/j.seminhematol.2016.04.017.

Walker UA et al. (2016) ‘Brief Report: Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes.’, 68(2). Available at: https://doi.org/10.1002/art.39482.

Walker UA et al. (2016) ‘Rituximab done: what’s next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.’, 55(2). Available at: https://doi.org/10.1093/rheumatology/kev297.

Avouac J et al. (2016) ‘Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.’, Annals of the rheumatic diseases. 27.08.2014, 75(1), pp. 103–9. Available at: https://doi.org/10.1136/annrheumdis-2014-205295.

Elhai M et al. (2016) ‘A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.’, Annals of the rheumatic diseases. 23.10.2014, 75(1), pp. 163–9. Available at: https://doi.org/10.1136/annrheumdis-2014-206386.

Giaglis, S., Hahn, S. and Hasler, P. (2016) ‘‘The NET Outcome’: Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood?’, Front Pediatr, 4, p. 97. Available at: https://doi.org/10.3389/fped.2016.00097.

Giaglis, Stavros et al. (2016) ‘Neutrophil migration into the placenta: Good, bad or deadly?’, Cell Adh Migr, 10(1-2), pp. 208–25. Available at: https://doi.org/10.1080/19336918.2016.1148866.

Giaglis, Stavros et al. (2016) ‘Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF’, Frontiers in Immunology, 7, p. 565. Available at: https://doi.org/10.3389/fimmu.2016.00565.

Hasler, Paul, Giaglis, Stavros and Hahn, Sinuhe (2016) ‘Neutrophil extracellular traps in health and disease’, Swiss Medical Weekly, 146, p. w14352. Available at: https://doi.org/10.4414/smw.2016.14352.

Jaeger VK et al. (2016) ‘Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.’, PloS one, 11(10), p. e0163894. Available at: https://doi.org/10.1371/journal.pone.0163894.

Jordan S. et al. (2016) ‘Effect of endothelin-1 receptor antagonists on skin fibrosis in scleroderma patients from the EUSTAR database’, Journal of Scleroderma and Related Disorders, 1(2), pp. 220–225. Available at: https://doi.org/10.5301/jsrd.5000204.

Partovi S et al. (2016) ‘Quantitative dynamic contrast-enhanced ultrasound for the functional evaluation of the skeletal muscle microcirculation in systemic sclerosis.’, Clinical hemorheology and microcirculation, 62(1), pp. 35–44. Available at: https://doi.org/10.3233/ch-151929.

Sur Chowdhury, Chanchal et al. (2016) ‘Elevated Levels of Total Cell-Free DNA in Maternal Serum Samples Arise from the Generation of Neutrophil Extracellular Traps’, Fetal diagnosis and therapy, 40(4), pp. 263–267. Available at: https://doi.org/10.1159/000444853.

Ingegnoli F. et al. (2015) ‘A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study’, Microvascular Research, 102, pp. 19–24. Available at: https://doi.org/10.1016/j.mvr.2015.07.007.